We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Lorenzo's Oil Prevents Pediatric Disorder

By Biotechdaily staff writers
Posted on 27 Jul 2005
A new study has shown that use of a treatment known as Lorenzo's Oil may prevent a pediatric disorder called x-linked adrenoleukodystrophy (X-ALD) from developing in young boys diagnosed with the disorder but not yet showing signs of it.

The study involved 89 boys, aged seven and younger, who tested positive for an abnormal gene that identifies X-ALD. More...
Over a period of seven years, researchers treated the boys with daily oral doses of Lorenzo's Oil, a combination of two fats extracted from olive oil and rapeseed oil, and moderately restricted their dietary fat. All patients had a normal brain scan and showed no neurologic signs and symptoms of X-ALD prior to the study. At the completion of the study, 74% of the 89 patients showed no signs of disease progression. The researchers correlated greater compliance with a lower risk of developing the disease. This is the first time that the preventive effects of Lorenzo's Oil have been demonstrated by rigorous and scientifically accepted research methods.

X-ALD causes the breakdown of myelin, a fatty substance that acts as an insulator around nerve fibers. Symptoms appear between ages four and 10, and can lead to nerve deterioration, loss of verbal communication, and eventually to complete breakdown of body function.

"This finding is an exciting progression of the research to which my associates and I have dedicated ourselves to help these children,” observed lead author Hugo Moser, M.D., director of the Neurogenetics Research Center at the Kennedy Krieger Institute (Baltimore, MD, USA).

There is still no cure for X-ALD, and treatment options are limited to hormone therapy and bone marrow transplants. Lorenzo's Oil was invented by Augusto and Michaela Odone, whose son, Lorenzo, was diagnosed with X-ALD. Although the oil cannot repair damage already done, it can prevent the disease from progressing into a degenerative state. In spite of the fact that Lorenzo already showed symptoms before taking the oil, the treatment stopped the progression of his disease, and he celebrated his 27th birthday in May 2005. The story of the Odone family's struggle was dramatized in the 1992 motion picture entitled "Lorenzo's Oil.”





Related Links:
Kennedy Krieger Institute

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Silver Member
Connectivity Solution
EKF Link
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: Schematic overview of the CRISPR-Assisted Nanodroplet-pairing Platform for Differential Identification of NTM (CANDI). The platform combines broad-range amplification using conserved regions of the 16S and 23S rRNA genes with species-specific CRISPR recognition. Fluorescence-coded CRISPR droplets are paired with sample droplets containing amplified products, enabling multiplexed target recognition and signal decoding (Image Credit: Yiwen Yang, Jingsong Xu, Dakang Xu)

Nanodroplet CRISPR Technology Supports Rapid, Multiplexed Mycobacterial Identification

Mycobacterial infections are difficult to diagnose because closely related species can have different clinical and therapeutic implications. Nontuberculous mycobacteria (NTM) are increasingly recognized... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.